Bevacizumab in Combination with Irinotecanand Capecitabine as First-Line Treatment for MCRC - Efficacy and Safety (Meeting Abstract)

Title

Identifier

/unibl/sci/idNaucniRad:13157

info:doi/doi: 10.1093/annonc/mdu165.175

Type

See all items with this valueConference Paper

See all items with this valuetext

Date

See all items with this value2014

Bibliographic Citation

S. Jungić, G. Kecman Malčić, I. Rakita, D. Jovanović, R. Gajanin, Z. Marić, Z. Gojković, B. Tubić, Bevacizumab in Combination with Irinotecanand Capecitabine as First-Line Treatment for MCRC - Efficacy and Safety (Meeting Abstract), Annals of Oncology, Vol. 25(2), pp. 68 - 68, 2014

References

http://annonc.oxfordjournals.org/content/25/suppl_2/ii68.3.full

page start

page end

presented at

This article appears in:ESMO 16th World Congress on Gastrointestinal Cancer, 25–28 June 2014, Barcelona, Spain

Is Part Of

See all items with this valueAnnals of Oncology, Vol. 25(2)

list of authors

See all items with this value Saša Jungić

See all items with this value Gordana Kecman Malčić

See all items with this value Ivanka Rakita

See all items with this value Dušan Jovanović

See all items with this value Radoslav Gajanin

See all items with this value Zdravko Marić

See all items with this value Zdenka Gojković

See all items with this value Biljana Tubić

Position: 5329 (37 views)